Bcl-2 protein in diffuse large B-cell lymphoma

Bcl-2 protein in diffuse large B-cell lymphoma

Bibliographic Details
Main Author:	Viroj Wiwanitkit
Format:	Article
Language:	English
Published:	Associação Paulista de Medicina 2011-01-01
Series:	São Paulo Medical Journal
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802011000100011&lng=en&tlng=en

Similar Items

BCL2 overexpression in diffuse large B-cell Lymphoma
by: Hajar Masrour, et al.
Published: (2023-01-01)

Bcl-2 protein frequency in patients with high-risk diffuse large B-cell lymphoma
by: Abrahão Elias Hallack Neto, et al.

Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin
by: Jonathan Wawire, et al.
Published: (2019-04-01)

Primary cutaneous diffuse large B‐cell lymphoma, leg type with MYC/BCL2/BCL6 overexpression
by: Yosuke Okada, et al.
Published: (2022-02-01)

The survival impact of combined expression of myc, bcl2 and bcl6 in diffuse large b cell lymphoma patients
by: Adelina BIRCEANU COROBEA, et al.
Published: (2018-06-01)

"Interaction between BCL2 and JUN B in primary cutaneous lymphoma : A gene ontology approach": A comment on the new approach in dermatology
by: Wiwanitkit Viroj
Published: (2009-01-01)

Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
by: YunXiang Zhang, et al.
Published: (2019-01-01)

The pattern of CD15, CD30 and Bcl-2 expression in diffuse large B-cell lymphoma
by: Eow, G.I., et al.
Published: (2006)

Differentiated approach in the treatment of diffuse large B-cell lymphoma according to c-MYC and BCL2 status
by: R. K. Karakulov, et al.
Published: (2022-01-01)

Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma
by: Betül Bolat Küçükzeybek, et al.
Published: (2013-09-01)

MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.
by: Li-Xu Yan, et al.
Published: (2014-01-01)

Expression of CD5, CD1 0, Bcl-2 and Bcl-6 in diffuse large B cell lymphoma based on International Prognostic Index
by: Perpustakaan UGM, i-lib
Published: (2007)

Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma
by: Asmaa M. Ahmed, et al.
Published: (2021-08-01)

The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity.
by: Ryan C Thompson, et al.
Published: (2013-01-01)

Correction: MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Published: (2014-01-01)

Correction: MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
Published: (2014-01-01)

Correction: MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
by: Li-Xu Yan, et al.
Published: (2018-01-01)

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements, Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Rearrangement, and Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Cluster Amplification
by: Masashi Miyaoka, et al.
Published: (2022-11-01)

BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
by: Magdalena Klanova, et al.
Published: (2020-04-01)

Diffuse large B-cell lymphoma
by: Gatter, K, et al.
Published: (2010)

Targeting the Bcl-2 Family in B Cell Lymphoma
by: Clare M. Adams, et al.
Published: (2019-01-01)

Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma
by: Kun-Ming Chung, et al.
Published: (2013-07-01)

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
by: Nyman, H, et al.
Published: (2009)

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients
by: Yanjie Wang, et al.
Published: (2023-09-01)

P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMENTS IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL
by: F. Morschhauser, et al.
Published: (2022-06-01)

Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
by: Yan Qin, et al.
Published: (2022-06-01)

50% versus 70%: is there a difference between these BCL2 cut-offs in immunohistochemistry for diffuse large B-cell lymphomas (DLBCL)?
by: Cristiano Claudino Oliveira, et al.
Published: (2020-09-01)

BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas
by: Nyman, H, et al.
Published: (2008)

Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells
by: Peruničić-Jovanović Maja, et al.
Published: (2009-01-01)

Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence.
by: Agata M Bogusz, et al.
Published: (2017-01-01)

Association of pSTAT3, pSyk with c-Myc, p53, BCL2 proteins expression and survival of patients with diffuse large B-cell lymphoma
by: V. A. Rosin, et al.
Published: (2022-04-01)

BCL-2 GENE REARRANGEMENT AND PROTEIN EXPRESSION IN PRIMARY CUTANEOUS B-CELL LYMPHOMAS
by: Pezzella, F, et al.
Published: (1994)

Immunohistochemical expression of hedgehog proteins in diffuse large B-cell lymphoma
by: Azman, Siti Nur Lina
Published: (2016)

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma
by: Qinhua Liu, et al.
Published: (2022-08-01)

Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled Cohort
by: Bogyeong Han, et al.
Published: (2020-11-01)

Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma
by: Patricia Pérez-Galán, et al.
Published: (2023-02-01)

Characteristics of CD5-positive diffuse large B-cell lymphoma among Koreans: High incidence of BCL2 and MYC double-expressors.
by: Hee Young Na, et al.
Published: (2019-01-01)

Refractory diffuse large B-cell Lymphoma
by: Hajar Masrour, et al.
Published: (2023-01-01)

Diffuse Large B Cell Lymphoma of the Breast
by: Feryal Karaca, et al.
Published: (2015-03-01)

Transplant in Diffuse Large B-Cell Lymphoma
by: Guilherme Duffles, et al.
Published: (2022-06-01)